Moleculin Biotech Inc. (MBRX) Business News Jan. 13, 2026, 13:55 UTC Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects Full text
Register to leave comments News bot Jan. 13, 2026, 1:59 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical